Does Blocking DHT Affect Muscle Growth?

Blocking DHT with drugs like finasteride or dutasteride does not meaningfully impair muscle growth. Multiple clinical trials in men receiving testosterone therapy with and without DHT-blocking drugs have found virtually identical gains in lean mass and strength between groups. The reason comes down to how skeletal muscle processes hormones differently from tissues like the prostate or scalp, but the clinical picture is more interesting than a simple “no effect” answer.

Muscle Tissue Treats DHT Differently Than You’d Expect

DHT is often described as testosterone’s more powerful sibling. It binds the androgen receptor with roughly twice the affinity of testosterone and dissociates from it much more slowly, which is why it drives changes in tissues like the prostate and hair follicles so effectively.¹ So you’d think blocking it would hurt muscle gains. But skeletal muscle has an enzyme called 3-alpha hydroxysteroid dehydrogenase that rapidly deactivates DHT within the tissue itself.² In practice, DHT doesn’t stick around in muscle long enough to contribute meaningfully to growth. Testosterone itself, not its conversion to DHT, appears to be the dominant androgen for muscle.

There’s an additional wrinkle that makes testosterone’s slightly weaker receptor binding less relevant than it sounds on paper. When testosterone is present in relatively high concentrations, it overcomes the binding gap through sheer mass action, essentially flooding the receptor to compensate for its faster dissociation rate.¹ In a tissue like muscle, where testosterone circulates freely and DHT gets broken down almost immediately, this compensation means testosterone does the heavy lifting for androgen-receptor activation.

The Clinical Trials Are Surprisingly Clear

The strongest evidence comes from controlled human studies, and the results are consistent across different drugs, populations, and study designs. A well-known trial published in JAMA gave men suppressed testosterone production and then administered graded doses of testosterone alongside either dutasteride (which blocks both forms of the enzyme that converts testosterone to DHT) or placebo. The gains in fat-free mass tracked with testosterone dose, not with whether DHT was blocked. The difference between the two groups was about half a kilogram and was not statistically significant. Leg-press and chest-press strength also increased with testosterone dose, and again, the relationship was the same whether or not dutasteride was present.³

A similar pattern showed up in a trial of transgender men already on testosterone therapy. Adding dutasteride did not impair the increases in lean mass or reductions in fat mass, and handgrip and lower-limb strength improved equally in both groups.⁴ And in older hypogonadal men given higher-than-replacement testosterone for 36 months, adding finasteride (which blocks one isoform of the converting enzyme rather than both) produced gains in lean body mass and grip strength that were statistically indistinguishable from testosterone alone.⁵

A separate trial in older hypogonadal men confirmed that adding finasteride to testosterone did not alter improvements in muscle strength, body composition, or bone mineral density, while it did prevent testosterone-induced prostate enlargement. The authors concluded directly that elevated DHT mediates prostate growth but is not required for musculoskeletal benefits.⁶ A 2025 review in Endocrine Reviews characterized this finding as settled, stating plainly that conversion of testosterone to DHT is not required for mediating its anabolic effects.⁷

Finasteride Versus Dutasteride Matters Less Than People Think

You’ll see people on forums argue that finasteride is “safer for gains” than dutasteride because finasteride blocks only the type 2 isoform of the converting enzyme, while dutasteride blocks both type 1 and type 2. The logic goes that some local DHT production might still occur in muscle with finasteride but not with dutasteride. The enzyme distribution data supports part of this: the type 2 isoform is concentrated in male reproductive tissues like the prostate, while the type 1 isoform is more broadly expressed, including in skin and liver.⁸ In bone, for example, mRNA levels of both isoforms are dramatically lower than in their peak-expression tissues.⁹

But when you look at the actual clinical data, the distinction between finasteride and dutasteride doesn’t appear to matter for muscle outcomes. The JAMA dutasteride trial and the finasteride trials in older men both show the same result: no loss of muscle gains. If residual DHT from the type 1 enzyme were making a critical contribution to muscle growth in finasteride users, you’d expect dutasteride users to do measurably worse. They don’t. The most straightforward explanation remains that DHT just isn’t a major driver of muscle anabolism regardless of which drug you use.

Your Muscles Can Make Their Own Hormones

One piece of biology that often surprises people: skeletal muscle doesn’t rely solely on hormones circulating through the bloodstream. Muscle tissue contains its own set of androgen-biosynthesizing enzymes, and it can convert the widely circulating precursor DHEA into both testosterone and DHT locally.¹⁰ Exercise itself ramps up the expression of these enzymes.¹¹

In rat models of type 2 diabetes, resistance training significantly elevated DHT levels within the muscle tissue itself, alongside increases in the enzymes responsible for producing it. When a 5-alpha reductase inhibitor was given chronically, it suppressed the training-induced rise in muscle DHT but did not abolish the other androgen changes or the muscle adaptations entirely.¹² In the same animal model, resistance exercise elevated muscle DHT levels acutely and activated signaling pathways associated with both protein synthesis and glucose uptake.¹³

This is where the picture gets more nuanced than the human clinical trials suggest on their own. In rats, local muscle DHT seems to play a role in the acute molecular response to exercise. But the human studies show that blocking DHT systemically doesn’t ultimately hurt the outcome you care about: the actual muscle and strength you gain over weeks and months. The most likely reconciliation is that when DHT is blocked, testosterone and other signaling pathways compensate effectively for the loss in humans performing regular training.

It’s also worth noting that in trained human subjects, one study found that neither serum testosterone nor intramuscular DHT increased significantly after a single bout of resistance exercise, despite clear activation of androgen-receptor signaling in muscle.¹⁴ The androgen receptor can be activated by mechanisms beyond just more hormone showing up, which further explains why blocking one metabolite doesn’t derail the process.

What DHT Does Affect That Might Matter to You

Saying DHT doesn’t affect muscle growth isn’t the same as saying it’s irrelevant to people who train. DHT has effects on tissues adjacent to muscle that could theoretically influence training capacity or injury risk, even if they don’t change how much muscle you build.

A recent study on human deep fascia, the connective tissue sheath that surrounds and compartmentalizes muscles, found that fascial fibroblasts express androgen receptors and respond to DHT in a dose-dependent way. At concentrations matching normal female physiology, DHT increased production of collagen I (the main structural collagen) and decreased collagen III relative to untreated controls.¹⁵ Whether blocking DHT alters fascia composition enough to change injury risk or tissue stiffness in exercising adults is unknown, but it’s the kind of question that has not been studied in the context of people taking finasteride for hair loss.

In a mouse model of amyotrophic lateral sclerosis (ALS), DHT treatment reduced muscle atrophy, preserved neuromuscular junction connections, and improved motor function. It also increased expression of IGF-1 in muscle, a growth factor with both muscle-building and nerve-protecting effects.¹⁶ This is an extreme disease model and doesn’t translate to healthy gym-goers, but it does illustrate that DHT has roles in the neuromuscular system beyond simple muscle hypertrophy. Whether long-term DHT suppression in healthy people affects neuromuscular junction health is an open question.

Satellite Cells and the Androgen Receptor in Muscle

Both testosterone and DHT can upregulate the androgen receptor in muscle satellite cells, which are the stem-cell-like precursors that contribute to muscle repair and growth. In cell culture, supraphysiological concentrations of both hormones modestly increased androgen receptor protein levels in these cells.¹⁷ The fact that both testosterone and DHT can do this means that losing DHT doesn’t leave satellite cells without a way to receive androgenic signals. Testosterone alone appears sufficient to keep the receptor populated and functional.

This is a subtle but important point: the concern people have about blocking DHT usually assumes that every tissue needs both hormones. In muscle, the redundancy between testosterone and DHT at the receptor level means losing one doesn’t create a void. The prostate, by contrast, depends heavily on local DHT because testosterone concentrations there aren’t high enough to compensate, which is exactly why finasteride and dutasteride shrink it so effectively.

Side Effects That Could Indirectly Affect Training

While DHT blockers don’t impair muscle growth through their hormonal mechanism, they do carry side effects that could affect your workouts through other routes. A systematic review and meta-analysis of trials using 5-alpha reductase inhibitors found roughly a 1.9-fold increased risk of sexual side effects and a non-significant trend toward increased physical side effects.¹⁸ Sexual side effects like reduced libido or erectile dysfunction are the most commonly reported, and in a small subset of users these symptoms persist after stopping the drug, a phenomenon known as post-finasteride syndrome. The biological basis of post-finasteride syndrome remains debated, with gene-expression studies finding some differences in affected patients but no consensus on mechanism.¹⁹

For training purposes, the side effects most likely to affect your gym performance are fatigue, mood changes, and reduced motivation, all of which some users report anecdotally. These are harder to quantify than lean mass or strength in a clinical trial. A person who feels chronically fatigued or has lower drive may train with less intensity or consistency, which would absolutely affect their results over time. The muscle tissue itself isn’t impaired, but the person attached to it might be.

What About People Not on Testosterone Therapy

Most of the clinical trials discussed above involved men receiving exogenous testosterone alongside the DHT blocker. This is the cleanest experimental setup because it controls the testosterone dose. But the majority of people taking finasteride or dutasteride for hair loss are young men with normal testosterone levels who aren’t on any kind of hormone therapy. Does the evidence still apply to them?

The mechanism strongly suggests it does. Blocking DHT conversion doesn’t lower your testosterone levels; in fact, finasteride tends to slightly raise total testosterone because less of it gets converted downstream. Your muscles still see the same or slightly more testosterone, which is the hormone doing the actual work in that tissue. The clinical trials showing no effect of DHT suppression on muscle are consistent across different populations: younger trans men, older hypogonadal men, and men with experimentally suppressed and then restored testosterone.⁴ The consistency across these groups makes it unlikely that young, otherwise healthy men represent a special exception.

That said, no large trial has specifically randomized naturally eugonadal young men to finasteride versus placebo and measured muscle growth over a full training program. The existing evidence is strong enough that most endocrinologists consider the question settled, but if you’re the type who wants a trial that exactly matches your situation, that specific study hasn’t been done.

DHT and Fascia Remodeling

An area of emerging research that hasn’t received much attention outside academic circles is how androgens, including DHT, affect the connective tissue matrix surrounding muscles. The fascia isn’t just passive wrapping; it transmits force between muscles and influences how muscles move and grow. The finding that fascial fibroblasts express androgen receptors and change their collagen composition in response to DHT opens questions about what happens to connective tissue integrity during long-term DHT suppression.¹⁵

Collagen I provides tensile strength, while collagen III is more compliant and is typically found in higher proportions during early wound healing. The study’s finding that DHT shifted the ratio toward more collagen I and less collagen III suggests DHT might help stiffen and strengthen fascia. Whether blocking DHT reverses this balance and what that would mean for injury susceptibility during heavy training are questions nobody has answered yet. This is speculative territory, but it’s the kind of gap in the evidence that people making long-term decisions about finasteride use should at least be aware of.

The Anabolic Steroid User’s Situation Is Different

Finasteride and dutasteride are sometimes used by anabolic steroid users to manage androgenic side effects like acne and hair loss while running testosterone or other compounds. The pharmacology is more complicated in this context. Some anabolic steroids are themselves substrates for the 5-alpha reductase enzyme, so blocking it changes the downstream metabolite profile in ways that don’t apply to someone on finasteride alone. Other steroids, like nandrolone, are actually made weaker rather than stronger by 5-alpha reduction, meaning a 5-alpha reductase inhibitor could paradoxically increase their androgenic effects in certain tissues.

The controlled clinical trials discussed in this article used pharmaceutical testosterone at defined doses. Their findings apply most directly to people taking finasteride or dutasteride alongside testosterone replacement therapy, or to natural individuals whose only circulating androgen is their own testosterone. If you’re running multiple compounds, the interaction effects are unpredictable from the existing evidence base, and the reassuring clinical trial data may not extend to that scenario.

What the Research Has Not Measured

Most studies on DHT blockade and muscle have measured lean body mass by body-scan techniques and strength by a few standard tests like handgrip, leg press, or chest press. These are reasonable endpoints, but they don’t capture everything a gym-goer cares about. No trial has measured recovery speed between workouts, muscle damage markers after eccentric exercise, tendon adaptation over a training block, or subjective measures of pump and workout quality. The 36-month finasteride study measured timed physical performance tests and found no difference, which is reassuring, but it was conducted in men over 65 who were not following a structured resistance-training program.⁵ Whether the same holds for a 25-year-old doing progressive overload four days a week hasn’t been directly tested, though the mechanistic evidence and the consistency across existing trials strongly suggest it would.